Today: 20 May 2026
Rocket Lab stock rebounds, holds after-hours bid as RKLB traders weigh insider sales and earnings clock

Rocket Lab stock rebounds, holds after-hours bid as RKLB traders weigh insider sales and earnings clock

NEW YORK, Jan 9, 2026, 17:36 EST — After-hours

  • Rocket Lab shares rose about 2.1% in regular trading and edged up in extended trade
  • SEC filings this week showed the CFO and COO sold stock under pre-set trading plans
  • Next focal point is fourth-quarter results, expected late February by several calendars

Rocket Lab Corp shares closed up 2.1% on Friday and were modestly higher in after-hours trading, as the space launch and satellite builder steadied after a choppy run. The stock ended the session at $84.85 and was around $85.12 in extended trade.

The move matters because Rocket Lab’s rally has pulled more short-term money into the name, and the tape has started reacting to filings and calendar risk rather than new contracts. Rocket Lab stock is up about 200% over the past 12 months, Barron’s reported this week, putting execution and timing back in focus.

That scrutiny sharpened after insider disclosures. Chief Financial Officer Adam Spice exercised options and sold about 1.37 million shares on Jan. 5 under a Rule 10b5-1 plan — a pre-arranged trading program that lets insiders buy or sell stock on a set schedule — while Chief Operating Officer Frank Klein sold 100,000 shares on Jan. 2 under a similar plan, SEC filings showed.

The bigger swing factor remains defense work. Rocket Lab said in December it won an $816 million Space Development Agency prime contract to build 18 missile-warning and tracking satellites, with options that could lift the award. “Rocket Lab is honored to play a role in enabling this,” founder and CEO Peter Beck said in the release. GlobeNewswire

The SDA Tranche-3 procurement totals about $3.5 billion across four firms — Rocket Lab, Lockheed Martin, Northrop Grumman and L3Harris — under fixed-price awards, Reuters reported at the time.

Investors now want to see that backlog turn into revenue without slipping schedules. In its November results update, Rocket Lab forecast fourth-quarter revenue of $170 million to $180 million and GAAP gross margin — profit after direct costs, under standard U.S. accounting rules — of 37% to 39%; it also said Neutron, its larger reusable rocket, should arrive at its Launch Complex 3 in the first quarter of 2026, with the first launch after qualification testing.

But the trade has a bad habit of punishing delays. Any stumble in launch cadence, a setback in Neutron qualification, or slower conversion of government orders into billed revenue could hit sentiment fast, especially with insiders selling stock on auto-pilot plans.

Rocket Lab has not announced a date for its fourth-quarter results, but several earnings calendars peg the report around Feb. 26. Traders will be listening for a clean read-through on margins, cash use and whether Neutron’s first launch is still tracking as the next milestone.

Stock Market Today

  • Trump's Truth Social Withdraws Bitcoin and Bitcoin-Ethereum ETF Applications Amid Market Pressure
    May 20, 2026, 7:22 AM EDT. Trump Media & Technology Group has withdrawn its applications for Bitcoin and Bitcoin-Ethereum exchange-traded funds (ETFs), citing a strategic shift to pursue a different regulatory framework under the Investment Company Act of 1940 ('40 Act) instead of the Securities Act of 1933 ('33 Act). Yorkville America, the investment advisor, highlighted that the '40 Act allows more flexible investment strategies. This move comes amid intense fee competition in the U.S. spot Bitcoin ETF market, valued at $57.4 billion since January 2024, following Morgan Stanley's MSBT launch, which offers a low 0.14% expense ratio. The withdrawal underscores heightened competition and evolving regulatory approaches in the crypto ETF space.

Latest articles

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

20 May 2026
InMed Pharmaceuticals shares fell 14.4% to $1.37 in early pre-market trading Wednesday, after surging 135% Tuesday on news of an all-stock merger with Mentari Therapeutics and a planned $290 million private placement. Pre-merger InMed shareholders are expected to own about 1.51% of the combined company, which will operate as Mentari Therapeutics and focus on migraine drug development.
Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

20 May 2026
Micware shares jumped 97.7% to $9.33 in premarket U.S. trading Wednesday, rebounding above last week’s $8 IPO price after closing Tuesday at $4.72. A new SEC filing showed Toyota owns 11.6% of Micware’s ordinary shares. The Japanese automotive software firm raised $22.8 million in its Nasdaq debut last week.
Dow edges up while Nasdaq falls as bond worries drag on

Futures Edge Higher Ahead of Nvidia Earnings as Wall Street Watches Key Report

20 May 2026
Nasdaq 100 futures rose 0.73% and S&P 500 futures gained 0.35% ahead of Wednesday’s open, with Nvidia set to report earnings after the close. Options markets priced in a 6.5% swing for Nvidia, equal to about $355 billion in market value. In premarket trading, Nvidia shares rose 1.84%, while Micron, Intel, and AMD also advanced. Fed minutes are due at 2:00 p.m. EDT.
Vistra stock jumps after Meta signs 20-year nuclear power deal to feed AI data centers
Previous Story

Vistra stock jumps after Meta signs 20-year nuclear power deal to feed AI data centers

Bank of America stock dips after-hours after $3 billion debt call, with earnings next week
Next Story

Bank of America stock dips after-hours after $3 billion debt call, with earnings next week

Go toTop